Skip to content
Home/Companies/Healthcare/Haihe Pharmaceutical

Haihe Pharmaceutical

Healthcare·China·Active
Entry
–
Hold
–
Status
Active

Who owns Haihe Pharmaceutical?

Haihe Pharmaceutical is currently owned by Warburg Pincus.

Hand-verified · updated 2026-04-21

Warburg Pincus
Investor
Warburg Pincus
Fund attribution unclassified.

Key facts

HQChina
SectorHealthcare

More from Warburg Pincus Other Investments

Other portfolio companies in the same fund.

58 Com
58 Com
Active
E-commerceFrance
Advance Intelligence Group
Advance Intelligence Group
Active
TMTSingapore
Afiona
Active
ConsumerUS
Allied Universal
Active
Business ServicesUS
Ant Financial
Active
TMTChina
Avanse Financial Services
Avanse Financial Services
Active
FinancialsIndia

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Haihe Pharmaceutical

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Haihe Pharmaceutical.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue